clinical trial tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo- controlled, phase 3 Clinical trials of subcutaneous tirzepatide

This comparison draws on peer-reviewed clinical data, FDA documentation, and the latest Phase 3 trial results to give you the most complete, evidence-based picture available

many of us have been there, questioning what more we could do to reach our goals

This mechanism suggests BPC 157 could be a valuable tool not just for the active phase of acne but for the recovery phase as well, helping to restore the skin's integrity

These levels can still induce gluconeogenesis and lipolysis

The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease

Mediterranean diet and cardiovascular risk factors: a systematic review